Τόμος 4 (1986) – Τεύχος 1 – Άρθρο 7 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 4 (1986) – Issue 1 – Article 7 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

^{Τμήμα Επιστημονικής Πληροφόρησης ΦΑΡΜΑΚΟΝ-ΤΥΠΟΣ}

3: 290-299 (1986)

PHARMAKON-Press: Epitheorese Klin. Farmakol. Farmakokinet.

3: 290-299 (1986)

The basic etiologic process responsible for most coronary and cerebral vascular disease is atherosclerosis, a silent, hidden process that begins in most people before age 20 and progresses asymptomati­cally, often for decades. Not until more than two-thirds of a vessel is occluded in the coronary system does atherosclerosis mani­fest itself, for example, angina, heart attack or sudden death.

1. Consensus Conference. Lowering Blood Cholesterol to Prevent Heart Disease. J.A.M.A. 253: 2080 (1985)
2. Gotto, A.M. Jr.: Classification and structure of lipopro­teins. A Symposium: Laboratory Lipid Values. Am. J. Card., December 31, (1985)
3. Roheim, P.S.: Atherosclerosis and lipoprotein metabo­lism: Role of reverse cholesterol transport. Am. J. Card. 57: 3C (1986)
4. Fredrickson, D.S., Levy, R.I., Less, R.S.: Fat transport in lipoproteins – an integral approach to mechanisms and disorders. N. Engl. J. Med. 276: 34, 94, 148, 215, 273 (1967)
5. Havel, R.J.. Eder, H.A., Bragdon, J.H.: The distribution and chemical composition of ultra centrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345 ( 1955)